2019
DOI: 10.1111/codi.14588
|View full text |Cite
|
Sign up to set email alerts
|

Is the need for inflammatory bowel disease surgery diminishing in the biologic era?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 14 publications
0
4
0
Order By: Relevance
“…This study utilised a cohort of patients undergoing non‐elective admissions with UC in order to identify those patients who are more likely to require colectomy; hospitalisation for UC itself is a risk factor for subsequent colectomy 39 . The efficacy of modern medical salvage and its translation to long‐term colectomy avoidance has been scrutinised in the scientific literature 40,41 . In this study the modest decreases in short‐term colectomy rates are not reflected in medium‐term colectomy rates.…”
Section: Discussionmentioning
confidence: 99%
“…This study utilised a cohort of patients undergoing non‐elective admissions with UC in order to identify those patients who are more likely to require colectomy; hospitalisation for UC itself is a risk factor for subsequent colectomy 39 . The efficacy of modern medical salvage and its translation to long‐term colectomy avoidance has been scrutinised in the scientific literature 40,41 . In this study the modest decreases in short‐term colectomy rates are not reflected in medium‐term colectomy rates.…”
Section: Discussionmentioning
confidence: 99%
“…Independent of our conclusions, the most important outcome for people suffering from this life‐long relapsing condition is improved quality of life. Focusing on “colectomy‐free discharge” while relationships and jobs are lost and education is postponed is perhaps missing the wood for the trees 7,8 . Quality of life and decision‐making studies regarding UC surgery such as SOQCS and DISCUSS are welcome additions to the IBD research portfolio 9,10 .…”
Section: Figurementioning
confidence: 99%
“…Whether infliximab therapy has unequivocally provided a sustained reduction in colectomy rates long term continues to be debated. [19][20][21] Long-term follow-up of early trials demonstrated that colectomy was still required in up to 50% of patients following infliximab therapy at 5 years. [22][23][24][25] A recent UK population study also showed that while the short term colectomy rate was reduced for emergently admitted patients with at least moderate UC treated with infliximab, the colectomy free survival did not persist beyond 1 year and the rates of colectomy at 3 years were not significantly different to the pre biologic era.…”
Section: Introductionmentioning
confidence: 99%
“…Whether infliximab therapy has unequivocally provided a sustained reduction in colectomy rates long term continues to be debated 19–21 . Long‐term follow‐up of early trials demonstrated that colectomy was still required in up to 50% of patients following infliximab therapy at 5 years 22–25 .…”
Section: Introductionmentioning
confidence: 99%